Extended-spectrum beta-lactamase-producing Shigella strains in Israel, 2000-2004

V Vasilev1, R Japheth, R Yishai

  • 1Central Laboratories of the Ministry of Health, 9 Yaakov Eliav Street, P.O. Box 34410, Givat Shaul, Jerusalem 91342, Israel. valentin.vasilev@eliav.health.gov.il

Summary

Seven Shigella isolates resistant to ceftriaxone were identified, all producing extended-spectrum beta-lactamases (ESBLs). Molecular analysis revealed CTX-M-type enzymes as the primary cause of resistance in these Shigella strains.